HCA Healthcare, Inc. (NYSE:HCA) Shares Sold by Sax Wealth Advisors LLC

Sax Wealth Advisors LLC decreased its position in HCA Healthcare, Inc. (NYSE:HCA) by 16.1% during the fourth quarter, Holdings Channel reports. The firm owned 996 shares of the company’s stock after selling 191 shares during the quarter. Sax Wealth Advisors LLC’s holdings in HCA Healthcare were worth $299,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also modified their holdings of HCA. Benjamin F. Edwards & Company Inc. acquired a new position in HCA Healthcare in the 2nd quarter valued at about $33,000. Legacy Investment Solutions LLC acquired a new position in shares of HCA Healthcare in the third quarter valued at approximately $39,000. Canoe Financial LP purchased a new position in HCA Healthcare in the 3rd quarter valued at approximately $41,000. Capital Performance Advisors LLP purchased a new stake in shares of HCA Healthcare during the third quarter worth $41,000. Finally, Northwest Investment Counselors LLC purchased a new position in HCA Healthcare in the third quarter valued at $44,000. 62.73% of the stock is currently owned by hedge funds and other institutional investors.

HCA Healthcare Price Performance

Shares of NYSE:HCA opened at $310.60 on Friday. The stock has a market capitalization of $78.68 billion, a price-to-earnings ratio of 13.95, a PEG ratio of 1.03 and a beta of 1.64. HCA Healthcare, Inc. has a one year low of $278.50 and a one year high of $417.14. The company has a 50-day simple moving average of $316.69 and a 200-day simple moving average of $352.78. The company has a debt-to-equity ratio of 48.71, a quick ratio of 1.00 and a current ratio of 1.12.

HCA Healthcare Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, December 27th. Stockholders of record on Friday, December 13th were issued a $0.66 dividend. This represents a $2.64 dividend on an annualized basis and a dividend yield of 0.85%. The ex-dividend date of this dividend was Friday, December 13th. HCA Healthcare’s payout ratio is currently 11.85%.

Analyst Upgrades and Downgrades

Several equities analysts have recently issued reports on HCA shares. TD Cowen decreased their price objective on HCA Healthcare from $450.00 to $440.00 and set a “buy” rating for the company in a research note on Monday, October 28th. Raymond James downgraded shares of HCA Healthcare from an “outperform” rating to a “market perform” rating in a research report on Friday, November 22nd. Wells Fargo & Company downgraded shares of HCA Healthcare from an “equal weight” rating to an “underweight” rating and lowered their target price for the stock from $400.00 to $320.00 in a research note on Monday, November 25th. Oppenheimer lifted their price target on HCA Healthcare from $390.00 to $400.00 and gave the stock an “outperform” rating in a report on Monday, October 28th. Finally, KeyCorp decreased their target price on HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating for the company in a research note on Tuesday, January 7th. One investment analyst has rated the stock with a sell rating, three have issued a hold rating, twelve have assigned a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat.com, HCA Healthcare has a consensus rating of “Moderate Buy” and an average price target of $385.27.

Insider Activity at HCA Healthcare

In other HCA Healthcare news, SVP Phillip G. Billington sold 3,897 shares of the business’s stock in a transaction that occurred on Thursday, November 14th. The stock was sold at an average price of $350.00, for a total transaction of $1,363,950.00. Following the transaction, the senior vice president now owns 52,702 shares in the company, valued at approximately $18,445,700. The trade was a 6.89 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, insider Erol R. Akdamar sold 2,900 shares of HCA Healthcare stock in a transaction that occurred on Thursday, November 14th. The shares were sold at an average price of $353.00, for a total value of $1,023,700.00. Following the completion of the sale, the insider now owns 6,843 shares in the company, valued at approximately $2,415,579. This trade represents a 29.76 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.70% of the stock is currently owned by insiders.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.